LivaNova (LIVN) Cash & Current Investments (2014 - 2026)

LivaNova (LIVN) reported Cash & Current Investments of $539.7 million for Q1 2026, down 26.91% on a YoY basis from $738.4 million in Q1 2025, and down 15.08% sequentially from $635.6 million in Q4 2025.

LivaNova (LIVN) Cash & Current Investments (2014 - 2026) Analysis & Trends

LivaNova (LIVN) has 13 years of Cash & Current Investments data on file, last reported at $539.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 26.91% year-over-year to $539.7 million; the trailing twelve-month figure through Mar 2026 stood at $539.7 million (down 26.91% YoY), and the FY2025 full-year result was $635.6 million, up 48.2% from the prior year.
  • Cash & Current Investments declined to $539.7 million in Q1 2026, from $635.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $738.4 million in Q1 2025 to a low of $276.0 million in Q3 2022.
  • A 5-year average of $381.5 million and a median of $311.4 million in 2023 frame the typical range for Cash & Current Investments.
  • Peak annual rise in Cash & Current Investments reached 183.96% in 2022, while the deepest fall reached 30.93% in 2022.
  • Tracing LIVN's Cash & Current Investments over 5 years: stood at $302.8 million in 2022, then increased by 2.84% to $311.4 million in 2023, then jumped by 37.73% to $428.9 million in 2024, then surged by 48.2% to $635.6 million in 2025, then dropped by 15.08% to $539.7 million in 2026.
  • Business Quant data shows LIVN's Cash & Current Investments at $539.7 million in Q1 2026, $635.6 million in Q4 2025, and $738.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 LivaNova 4.40 Bn 3.86 Bn 243.75 Mn 539.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 539.71 Mn
Dec 31, 2025 635.55 Mn
Mar 31, 2025 738.44 Mn
Dec 31, 2024 428.86 Mn
Sep 30, 2024 346.37 Mn
Jun 30, 2024 303.88 Mn
Mar 31, 2024 306.50 Mn
Dec 31, 2023 311.37 Mn
Sep 30, 2023 298.80 Mn
Jun 30, 2023 311.43 Mn
Mar 31, 2023 308.60 Mn
Dec 31, 2022 302.78 Mn
Sep 30, 2022 275.96 Mn
Jun 30, 2022 300.27 Mn
Mar 31, 2022 313.68 Mn
Dec 31, 2021 106.63 Mn
Sep 30, 2021 277.77 Mn
Jun 30, 2021 434.76 Mn
Mar 31, 2021 252.54 Mn
Dec 31, 2020 254.89 Mn